These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9081371

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.
    Finlay GJ, Holdaway KM, Baguley BC.
    Cancer Chemother Pharmacol; 1994; 34(2):159-65. PubMed ID: 8194167
    [Abstract] [Full Text] [Related]

  • 24. Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients.
    Csoka K, Nygren P, Graf W, Påhlman L, Glimelius B, Larsson R.
    Int J Cancer; 1995 Nov 03; 63(3):356-60. PubMed ID: 7591231
    [Abstract] [Full Text] [Related]

  • 25. Apoptosis induced by calcein acetoxymethyl ester in the human histiocytic lymphoma cell line U-937 GTB.
    Liminga G, Martinsson P, Jonsson B, Nygren P, Larsson R.
    Biochem Pharmacol; 2000 Dec 15; 60(12):1751-9. PubMed ID: 11108790
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients.
    Laryea D, Isaksson A, Wright CW, Larsson R, Nygren P.
    Invest New Drugs; 2009 Oct 15; 27(5):402-11. PubMed ID: 18853102
    [Abstract] [Full Text] [Related]

  • 28. Cytotoxic activity of topoisomerase II inhibitors in primary cultures of tumor cells from patients with human hematologic and solid tumors.
    Larsson R, Nygren P.
    Cancer; 1994 Nov 15; 74(10):2857-62. PubMed ID: 7954248
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of the P-gp pump function on leukemic cell membrane and proper application of its reversal agents with Calcein-AM and flow cytometry].
    Lan ZJ, Tang YM, Shen HQ, Qian BQ, Ning BT, Chen YH.
    Zhonghua Er Ke Za Zhi; 2007 May 15; 45(5):334-8. PubMed ID: 17697617
    [Abstract] [Full Text] [Related]

  • 30. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
    Essodaigui M, Broxterman HJ, Garnier-Suillerot A.
    Biochemistry; 1998 Feb 24; 37(8):2243-50. PubMed ID: 9485370
    [Abstract] [Full Text] [Related]

  • 31. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    Nygren P, Larsson R.
    Int J Cancer; 1991 Jun 19; 48(4):598-604. PubMed ID: 2045203
    [Abstract] [Full Text] [Related]

  • 32. Calcein-AM is a detector of intracellular oxidative activity.
    Uggeri J, Gatti R, Belletti S, Scandroglio R, Corradini R, Rotoli BM, Orlandini G.
    Histochem Cell Biol; 2004 Nov 19; 122(5):499-505. PubMed ID: 15503120
    [Abstract] [Full Text] [Related]

  • 33. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ.
    Br J Cancer; 1995 Sep 19; 72(3):543-9. PubMed ID: 7669559
    [Abstract] [Full Text] [Related]

  • 34. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H, Nygren P, Dhar S, Csoka K, Kristensen J, Larsson R.
    J Exp Ther Oncol; 1996 Sep 19; 1(5):286-95. PubMed ID: 9414416
    [Abstract] [Full Text] [Related]

  • 35. Calcein AM release-based cytotoxic cell assay for fish leucocytes.
    Iwanowicz LR, Densmore CL, Ottinger CA.
    Fish Shellfish Immunol; 2004 Feb 19; 16(2):127-37. PubMed ID: 15123317
    [Abstract] [Full Text] [Related]

  • 36. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity.
    Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R.
    J Immunol Methods; 1994 Jun 24; 172(2):227-39. PubMed ID: 7518485
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Larsson R, Nygren P, Ekberg M, Slater L.
    Leukemia; 1990 Aug 24; 4(8):567-71. PubMed ID: 2388483
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).
    Duffy CP, Elliott CJ, O'Connor RA, Heenan MM, Coyle S, Cleary IM, Kavanagh K, Verhaegen S, O'Loughlin CM, NicAmhlaoibh R, Clynes M.
    Eur J Cancer; 1998 Jul 24; 34(8):1250-9. PubMed ID: 9849488
    [Abstract] [Full Text] [Related]

  • 39. Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging.
    Bratosin D, Mitrofan L, Palii C, Estaquier J, Montreuil J.
    Cytometry A; 2005 Jul 24; 66(1):78-84. PubMed ID: 15915509
    [Abstract] [Full Text] [Related]

  • 40. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
    Page RL, Hughes CS, Huyan S, Sagris J, Trogdon M.
    Anticancer Res; 2000 Jul 24; 20(5B):3533-8. PubMed ID: 11131658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.